カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の10価肺炎球菌結合型ワクチン市場予測2023-2029：単回投与バイアル、プレフィルドシリンジ

【英語タイトル】10-Valent Pneumococcal Polysaccharide Vaccine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8767）・商品コード：MMG23LY8767
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：70
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の10価肺炎球菌結合型ワクチン市場規模と予測を収録しています。・世界の10価肺炎球菌結合型ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の10価肺炎球菌結合型ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の10価肺炎球菌結合型ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「単回投与バイアル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

10価肺炎球菌結合型ワクチンのグローバル主要企業は、GSKなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、10価肺炎球菌結合型ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の10価肺炎球菌結合型ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の10価肺炎球菌結合型ワクチン市場：タイプ別市場シェア、2022年
・単回投与バイアル、プレフィルドシリンジ

世界の10価肺炎球菌結合型ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の10価肺炎球菌結合型ワクチン市場：用途別市場シェア、2022年
・病院、クリニック

世界の10価肺炎球菌結合型ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の10価肺炎球菌結合型ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における10価肺炎球菌結合型ワクチンのグローバル売上、2018年-2023年
・主要企業における10価肺炎球菌結合型ワクチンのグローバル売上シェア、2022年
・主要企業における10価肺炎球菌結合型ワクチンのグローバル販売量、2018年-2023年
・主要企業における10価肺炎球菌結合型ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GSK

*************************************************************

・調査・分析レポートの概要
10価肺炎球菌結合型ワクチン市場の定義
市場セグメント
世界の10価肺炎球菌結合型ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の10価肺炎球菌結合型ワクチン市場規模
世界の10価肺炎球菌結合型ワクチン市場規模：2022年 VS 2029年
世界の10価肺炎球菌結合型ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの10価肺炎球菌結合型ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の10価肺炎球菌結合型ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：単回投与バイアル、プレフィルドシリンジ
10価肺炎球菌結合型ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、クリニック
10価肺炎球菌結合型ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別10価肺炎球菌結合型ワクチン市場規模 2022年と2029年
地域別10価肺炎球菌結合型ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
GSK
...

Pneumococcal conjugate 10-valent vaccine – consisting of 1 microgram of polysaccharide for serotypes 1, 5, 6B, 7F, 9V, 14 and 23F, and 3 micrograms of serotypes 4, 18C and 19F.
This report aims to provide a comprehensive presentation of the global market for 10-Valent Pneumococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 10-Valent Pneumococcal Polysaccharide Vaccine. This report contains market size and forecasts of 10-Valent Pneumococcal Polysaccharide Vaccine in global, including the following market information:
Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five 10-Valent Pneumococcal Polysaccharide Vaccine companies in 2022 (%)
The global 10-Valent Pneumococcal Polysaccharide Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Single Dose Vial Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of 10-Valent Pneumococcal Polysaccharide Vaccine include GSK. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the 10-Valent Pneumococcal Polysaccharide Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 10-Valent Pneumococcal Polysaccharide Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Segment Percentages, by Type, 2022 (%)
Single Dose Vial
Pre-filled Syringe
Global 10-Valent Pneumococcal Polysaccharide Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Global 10-Valent Pneumococcal Polysaccharide Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies 10-Valent Pneumococcal Polysaccharide Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies 10-Valent Pneumococcal Polysaccharide Vaccine revenues share in global market, 2022 (%)
Key companies 10-Valent Pneumococcal Polysaccharide Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies 10-Valent Pneumococcal Polysaccharide Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Outline of Major Chapters:
Chapter 1: Introduces the definition of 10-Valent Pneumococcal Polysaccharide Vaccine, market overview.
Chapter 2: Global 10-Valent Pneumococcal Polysaccharide Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of 10-Valent Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of 10-Valent Pneumococcal Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global 10-Valent Pneumococcal Polysaccharide Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 10-Valent Pneumococcal Polysaccharide Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Overall Market Size
2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size: 2022 VS 2029
2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top 10-Valent Pneumococcal Polysaccharide Vaccine Players in Global Market
3.2 Top Global 10-Valent Pneumococcal Polysaccharide Vaccine Companies Ranked by Revenue
3.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Companies
3.4 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Companies
3.5 Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 10-Valent Pneumococcal Polysaccharide Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers 10-Valent Pneumococcal Polysaccharide Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 10-Valent Pneumococcal Polysaccharide Vaccine Players in Global Market
3.8.1 List of Global Tier 1 10-Valent Pneumococcal Polysaccharide Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 10-Valent Pneumococcal Polysaccharide Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size Markets, 2022 & 2029
4.1.2 Single Dose Vial
4.1.3 Pre-filled Syringe
4.2 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue & Forecasts
4.2.1 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2018-2023
4.2.2 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2024-2029
4.2.3 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales & Forecasts
4.3.1 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2018-2023
4.3.2 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2024-2029
4.3.3 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue & Forecasts
5.2.1 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2018-2023
5.2.2 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2024-2029
5.2.3 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales & Forecasts
5.3.1 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2018-2023
5.3.2 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2024-2029
5.3.3 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2022 & 2029
6.2 By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue & Forecasts
6.2.1 By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2018-2023
6.2.2 By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2024-2029
6.2.3 By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales & Forecasts
6.3.1 By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2018-2023
6.3.2 By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2024-2029
6.3.3 By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2018-2029
6.4.2 By Country – North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2018-2029
6.4.3 US 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.4.4 Canada 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.4.5 Mexico 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2018-2029
6.5.3 Germany 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5.4 France 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5.5 U.K. 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5.6 Italy 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5.7 Russia 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5.9 Benelux 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2018-2029
6.6.3 China 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.6.4 Japan 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.6.5 South Korea 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.6.7 India 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2018-2029
6.7.2 By Country – South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2018-2029
6.7.3 Brazil 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.7.4 Argentina 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2018-2029
6.8.3 Turkey 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.8.4 Israel 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.8.6 UAE 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK 10-Valent Pneumococcal Polysaccharide Vaccine Major Product Offerings
7.1.4 GSK 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 GSK Key News & Latest Developments
8 Global 10-Valent Pneumococcal Polysaccharide Vaccine Production Capacity, Analysis
8.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Production Capacity, 2018-2029
8.2 10-Valent Pneumococcal Polysaccharide Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 10-Valent Pneumococcal Polysaccharide Vaccine Supply Chain Analysis
10.1 10-Valent Pneumococcal Polysaccharide Vaccine Industry Value Chain
10.2 10-Valent Pneumococcal Polysaccharide Vaccine Upstream Market
10.3 10-Valent Pneumococcal Polysaccharide Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 10-Valent Pneumococcal Polysaccharide Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of 10-Valent Pneumococcal Polysaccharide Vaccine in Global Market
Table 2. Top 10-Valent Pneumococcal Polysaccharide Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers 10-Valent Pneumococcal Polysaccharide Vaccine Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers 10-Valent Pneumococcal Polysaccharide Vaccine Product Type
Table 9. List of Global Tier 1 10-Valent Pneumococcal Polysaccharide Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 10-Valent Pneumococcal Polysaccharide Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2024-2029
Table 46. GSK Company Summary
Table 47. GSK 10-Valent Pneumococcal Polysaccharide Vaccine Product Offerings
Table 48. GSK 10-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. GSK Key News & Latest Developments
Table 50. 10-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global 10-Valent Pneumococcal Polysaccharide Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global 10-Valent Pneumococcal Polysaccharide Vaccine Production by Region, 2018-2023 (K Units)
Table 53. Global 10-Valent Pneumococcal Polysaccharide Vaccine Production by Region, 2024-2029 (K Units)
Table 54. 10-Valent Pneumococcal Polysaccharide Vaccine Market Opportunities & Trends in Global Market
Table 55. 10-Valent Pneumococcal Polysaccharide Vaccine Market Drivers in Global Market
Table 56. 10-Valent Pneumococcal Polysaccharide Vaccine Market Restraints in Global Market
Table 57. 10-Valent Pneumococcal Polysaccharide Vaccine Raw Materials
Table 58. 10-Valent Pneumococcal Polysaccharide Vaccine Raw Materials Suppliers in Global Market
Table 59. Typical 10-Valent Pneumococcal Polysaccharide Vaccine Downstream
Table 60. 10-Valent Pneumococcal Polysaccharide Vaccine Downstream Clients in Global Market
Table 61. 10-Valent Pneumococcal Polysaccharide Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. 10-Valent Pneumococcal Polysaccharide Vaccine Segment by Type in 2022
Figure 2. 10-Valent Pneumococcal Polysaccharide Vaccine Segment by Application in 2022
Figure 3. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. 10-Valent Pneumococcal Polysaccharide Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by 10-Valent Pneumococcal Polysaccharide Vaccine Revenue in 2022
Figure 9. By Type - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global 10-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit), 2018-2029
Figure 13. By Application - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global 10-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit), 2018-2029
Figure 17. By Region - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
Figure 23. US 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
Figure 28. Germany 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
Figure 37. China 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global 10-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production 10-Valent Pneumococcal Polysaccharide Vaccine by Region, 2022 VS 2029
Figure 54. 10-Valent Pneumococcal Polysaccharide Vaccine Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の10価肺炎球菌結合型ワクチン市場予測2023-2029：単回投与バイアル、プレフィルドシリンジ] (コード：MMG23LY8767)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の10価肺炎球菌結合型ワクチン市場予測2023-2029：単回投与バイアル、プレフィルドシリンジ]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のポリマーベース・プレフィルドシリンジ市場2022年：シングルチャンバーポリマーベース・プレフィルドシリンジ、デュアルチャンバーポリマーベース・プレフィルドシリンジ、カスタマイズポリマーベース・プレフィルドシリンジ
  • 世界の組換え活性型凝固第VII因子市場予測2023-2029：バイアル、プレフィルドシリンジ
  • 世界の薬剤・装置複合製品市場予測2023-2029：薬剤溶出ステント、プレフィルドシリンジ、ウェアラブル注射器、インスリン注射器用薬剤、その他
  • 組換えヒト凝固VIIaのグローバル市場2023年：プレフィルドシリンジ、バイアル
  • 世界の医薬品ガラス容器市場2022年：ガラス管注射ボトル、アンプル、プレフィルドシリンジ、カートリッジ、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆